Cheng et al. reported that miR-199a suppresses the tumorigenicity and chemoresistance of ovarian CSCs/TICs (CD44+CD117+ population) enriched from human primary ovarian tumor tissues [78]. This evidence concerns the gene KIT and ovarian neoplasm.